scispace - formally typeset
H

Hiroyuki Mano

Researcher at University of Tokyo

Publications -  308
Citations -  24554

Hiroyuki Mano is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 66, co-authored 275 publications receiving 22190 citations. Previous affiliations of Hiroyuki Mano include Astellas Pharma & Nagasaki University.

Papers
More filters
Journal ArticleDOI

In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

TL;DR: The present findings suggest that the simultaneous administration of STI571 with other agents except methotrexate would be advantageous for cytotoxic effects against Ph(+) leukemias and these combinations would be worthy of clinical trials.
Journal ArticleDOI

Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis

TL;DR: This work discovered novel microRNA candidates using two approaches: testing of computationally predicted microRNAs by a modified microarray-based detection system and cloning and sequencing of large numbers of small RNAs from different human and mouse tissues.
Journal ArticleDOI

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.

TL;DR: KLC1-ALK is the first novel oncogenic fusion identified using only FFPE tissues, and this finding will broaden the potential value of archival FFPe tissues and provide further biological and clinical insights into ALK-positive lung cancer.
Journal ArticleDOI

MCPIP1 Ribonuclease Antagonizes Dicer and Terminates MicroRNA Biogenesis through Precursor MicroRNA Degradation

TL;DR: The presence of this abortive processing machinery and diversity of MCPIP1-related genes may imply a dynamic evolutional transition of the RNA silencing system, and suggest that the balance between processing and destroying ribonucleases modulates miRNA biogenesis and potentially affects pathological miRNA dysregulation.